Financing channel feed – Endpoints News

Financing channel feed

23andMe weighs a sale as cash dwindles

3 months ago

Atalanta gets $97M boost to take two siRNAs into clinic for rare neuro disorders

3 months ago

Versant's fourth obesity biotech starts with $65M and a GIP antagonist

3 months ago

Cell therapy startup Aurion files for IPO, despite ongoing legal battle with investor Alcon

3 months ago

Metsera outlines $250M IPO plans as obesity biotech competition rises

3 months ago

Maze looks to lead IPO queue with $113M Nasdaq debut

3 months ago

With Sam Altman’s help, Retro Biosciences eyes $1B to extend lifespan by 10 years

4 months ago

Obesity biotech Aardvark files for IPO to advance oral, hunger-suppressing drug

4 months ago

Ascentage estimates $133M in proceeds as it plans Nasdaq dual listing

4 months ago

Sionna and Odyssey end JPM week with IPO filings

4 months ago

Shionogi lands $375M from HHS to develop preventive drug for Covid-19

4 months ago

Vaccine patch startup collects an additional $16M to Series A

4 months ago

Lykos upheaval continues with four new board exits amid hunt for cash

4 months ago

Umoja’s $100M Series C will advance its bid for more convenient cell therapies

4 months ago

Health tech funding in 2025 kicks off with megarounds

4 months ago

Normunity nabs $75M Series B to advance T cell engager and launch first trial

4 months ago

Aragen gets $100M from private equity firm to expand manufacturing footprint

4 months ago

Exclusive: Bucking gene editing downturn, Tune raises $175M to bring epigenetic editing to clinic

4 months ago

Chasing the next wave of obesity drugs, Metsera files for an IPO

4 months ago

Lilly finances new $500M biotech fund managed by a16z

4 months ago

Exclusive: Moderna's former top scientist has a new startup using AI to improve mRNA therapies

4 months ago

Four biotechs emerge with $800M and in-licensed assets on Friday

4 months ago

With $120M, GSK-allied Ouro Medicines throws its hat into burgeoning TCE ring

4 months ago

Cell therapy startup A2 Biotherapeutics nets $80M Series C

4 months ago

First page Previous page 2 3 456 7 8 Next page Last page